MODEL-AD
Generating and characterizing mouse models of late-onset Alzheimer’s disease to improve AD target discovery and validation
The MODEL-AD (Model Organism Development and Evaluation for Late-Onset Alzheimer’s Disease) consortium is a group of researchers focused on rigorous generation and characterization of fifty new mouse models of late-onset Alzheimer’s disease. Alzheimer’s disease (AD) is a debilitating illness with no known disease-modifying therapy. Furthermore, 99.3% of phase III clinical trials have failed for AD drug discovery.
The goal of the MODEL-AD consortium is to improve target discovery and validation efforts in AD by creating a community resource of mouse models that closely reflect the sporadic late-onset human form of AD. The group has focused on human AD genetics and systems biology resources such as Accelerating Medicine Partnership for AD (AMP-AD), AD Sequencing Project (ADSP), and AD Neuroimaging Initiative (ADNI) to prioritize specific variants to introduce into the mice to capture different aspects of the disease. All data – including ‘omics, imaging, and drug treatment – generated on the mouse models are actively distributed to the AD research community and public via the AD Knowledge Portal.
More Scientific Coordination Projects
Multi-Consortia Coordinating (MC2) Center
Sage Bionetworks leads the Multi-Consortia Coordinating (MC2) Center for six research consortia from the NIH/NCI Division of Cancer Biology. The MC2 Center aims to catalyze...
Learn MoreThe Gray Foundation
The Gray Foundation "Team Science" philanthropic initiative funds a network of researchers to study new approaches for the early detection, diagnosis, and therapy of BRCA-related...
Learn MoreThe First 1000 Days 1kD
The 1kD program is an international effort to better understand executive development in toddlers up to 1000 days old.
Learn More